Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)
Open Access
- 1 February 2018
- journal article
- review article
- Published by SAGE Publications in Cell Transplantation
- Vol. 27 (2), 310-324
- https://doi.org/10.1177/0963689717746999
Abstract
Cell therapy has been shown to be a key clinical therapeutic option for central nervous system diseases or damage. Standardization of clinical cell therapy procedures is an important task for professional associations devoted to cell therapy. The Chinese Branch of the International Association of Neurorestoratology (IANR) completed the first set of guidelines governing the clinical application of neurorestoration in 2011. The IANR and the Chinese Association of Neurorestoratology (CANR) collaborated to propose the current version “Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017)”. The IANR council board members and CANR committee members approved this proposal on September 1, 2016, and recommend it to clinical practitioners of cellular therapy. These guidelines include items of cell type nomenclature, cell quality control, minimal suggested cell doses, patient-informed consent, indications for undergoing cell therapy, contraindications for undergoing cell therapy, documentation of procedure and therapy, safety evaluation, efficacy evaluation, policy of repeated treatments, do not charge patients for unproven therapies, basic principles of cell therapy, and publishing responsibility.Keywords
This publication has 191 references indexed in Scilit:
- Mesenchymal stem cell transplantation ameliorates motor function deterioration of spinocerebellar ataxia by rescuing cerebellar Purkinje cellsJournal of Biomedical Science, 2011
- Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson diseaseJCI Insight, 2011
- Subarachnoid Transplant of the Human Neuronal hNT2.19 Serotonergic Cell Line Attenuates Behavioral Hypersensitivity without Affecting Motor Dysfunction after Severe Contusive Spinal Cord InjuryNeurology Research International, 2011
- Vascular disease and stem cell therapiesBritish Medical Bulletin, 2011
- Cryopreservation of Human Stem Cells for Clinical Application: A ReviewTransfusion Medicine and Hemotherapy, 2011
- Long‐term magnetic resonance imaging of stem cells in neonatal ischemic injuryAnnals of Neurology, 2010
- Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral SclerosisArchives of Neurology, 2010
- Medial Ganglionic Eminence-Derived Neural Stem Cell Grafts Ease Spontaneous Seizures and Restore GDNF Expression in a Rat Model of Chronic Temporal Lobe EpilepsyThe International Journal of Cell Cloning, 2010
- Autologous olfactory ensheathing cell transplantation in human paraplegia: a 3-year clinical trialBrain, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006